Article

Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients

2022-09-20

Abstract excerpt

<title>Abstract</title> <p>Minimal residual disease (MRD) assays allow response assessment in patients with multiple myeloma (MM), and negativity is associated with improved survival outcomes. The role of highly sensitive next generation sequencing (NGS) MRD in combination with functional imaging remains to be validated. We performed a retrospective analysis on MM patients who underwent frontline autologous stem...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 407d3bfb-82f4-5080-bb18-6266caf3d872
DOI: 10.21203/rs.3.rs-2058259/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patientsDOI 10.21203/rs.3.rs-2058259/v1Read

Monitoring minimal residual disease in the bone marrow using next generation sequencing.Semantic proximity Read

Establishing Measurable Residual Disease Trajectories for Patients on Treatment for Newly Diagnosed Multiple Myeloma as Benchmark for Deployment of T-cell Redirection TherapySemantic proximity Read

Measurable Residual Disease (MRD) dynamics in Multiple Myeloma and the influence of Clonal Diversity Analyzed by Artificial IntelligenceSemantic proximity Read

Minimal residual disease in multiple myeloma: defining the role of next generation sequencing and flow cytometry in routine diagnostic useSemantic proximity Read

Molecular detection of minimal residual disease in multiple myelomaSemantic proximity Read

Minimal Residual Disease Assessment Within the Bone Marrow of Multiple Myeloma: A Review of Caveats, Clinical Significance and Future PerspectivesSemantic proximity Read

Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myelomaSemantic proximity Read

Minimal Residual Disease Assessment in the Context of Multiple Myeloma Treatment.Semantic proximity Read

Prognostic value of deep sequencing method for minimal residual disease detection in multiple myelomaSemantic proximity Read

Cell-free DNA Whole Genome Sequencing for Non-Invasive Minimal Residual Disease Detection in Multiple MyelomaSemantic proximity Read

Expression profile of CASSIOPEIA patients refines prognostic value of MRD negativity in multiple myelomaSemantic proximity Read

Prognostic and Therapeutic Implications of Measurable Residual Disease Detection Across Hematologic Malignancies: Clinical Impact on Relapse Prediction and Survival OutcomesSemantic proximity Read